Petra Financial Advisors’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $618K | Buy |
7,448
+71
| +1% | +$5.89K | 0.39% | 67 |
|
|
2025
Q1 | $598K | Sell |
7,377
-1,163
| -14% | -$94.3K | 0.49% | 46 |
|
|
2024
Q4 | $769K | Sell |
8,540
-464
| -5% | -$41.8K | 0.52% | 50 |
|
|
2024
Q3 | $890K | Buy |
9,004
+152
| +2% | +$15K | 0.59% | 46 |
|
|
2024
Q2 | $821K | Sell |
8,852
-100
| -1% | -$9.27K | 0.59% | 51 |
|
|
2024
Q1 | $849K | Sell |
8,952
-10
| -0.1% | -$949 | 0.62% | 47 |
|
|
2023
Q4 | $800K | Sell |
8,962
-1,679
| -16% | -$150K | 0.67% | 44 |
|
|
2023
Q3 | $777K | Sell |
10,641
-100
| -0.9% | -$7.3K | 0.65% | 49 |
|
|
2023
Q2 | $894K | Sell |
10,741
-82,020
| -88% | -$6.82M | 0.8% | 37 |
|
|
2023
Q1 | $3.42M | Buy |
92,761
+82,361
| +792% | +$3.04M | 3.39% | 9 |
|
|
2022
Q4 | $863K | Buy |
+10,400
| New | +$863K | 0.95% | 28 |
|